ProShare Advisors
ZOM

ProShare Advisors’s Zomedica Corp. ZOM Stock Holding History

ProShare Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,573,819
Closed -$515K – 2048
2023
Q4 		$515K Sell
2,573,819
-414,462
-14% -$72.8K ﹤0.01% 1021
2023
Q3 		$499K Buy
2,988,281
+38,380
+1% +$7.45K ﹤0.01% 917
2023
Q2 		$590K Buy
2,949,901
+819,163
+38% +$166K ﹤0.01% 880
2023
Q1 		$451K Buy
+2,130,738
New +$522K ﹤0.01% 951

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ProShare Advisors's ZOM Position: Q1 2024 in Review

ProShare Advisors sold out of Zomedica Corp. (ZOM) in Q1 2024, closing a stake of 2,573,819 shares — an estimated $515K sold.

ProShare Advisors first reported a position in ZOM in Q1 2023 and held it in 4 quarters. The position peaked at $590K in Q2 2023. 100 funds tracked by Wall St. Rank hold ZOM as of Q1 2024.

  • ProShare Advisors reported no remaining Zomedica Corp. position as of Q1 2024 after selling out during the quarter.
  • ProShare Advisors sold 2,573,819 Zomedica Corp. shares in Q1 2024, an estimated $515K.
  • ProShare Advisors first reported a position in Zomedica Corp. in Q1 2023 and held it in 4 quarters.
  • ProShare Advisors's Zomedica Corp. position peaked at $590K in Q2 2023.
  • 100 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2024.

Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.